Skip to content

Peripheral inflammatory cytokines in adult epilepsy patients with anxiety disorders: case-controlled study

Peripheral inflammatory cytokines in adult epilepsy patients with anxiety disorders: case-controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024802
Enrollment
Unknown
Registered
2019-07-28
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Health Group:Without Intervention
Anxiety Disorders Group:Without Intervention
Epilepsy Group:Without Intervention
Epilepsy Comorbid Anxiety Disorders Group:Without Intervention

Sponsors

The 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Years of Education > 6 years; 3. All subjects must be volunteers and willing to sign the written informed consent; 4. The patients must meet the definitions for the terms epileptic seizure and epilepsy and the classification of seizure types issued by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) in the year of 2014 and 2017 respectively; 5. Generalized Anxiety Disorder-7 self-report scale (GAD-7) confirms anxiety; 6. The patients must be diagnosed as Anxiety Disorder based on the diagnostic criteria of Mini-International Neuropsychiatric Interview(MINI)which is in according with Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); 7. Patients have received the antiepileptic drugs(AED)therapy and the plasma concentration of AED reached the steady-state.

Exclusion criteria

Exclusion criteria: 1.Symptomatic epilepsy; 2.Severe or extensive brain damage; 3.The patients have taken antipsychoticsantidepressants or anti-anxiety medicines for some time. 4.The patients have other accompanying diseases besides epilepsy. 5.The patients lack understanding and communication ability to comply. 6.The patients have hearing loss or speech disorder. 7.The patients have consciousness impairment and status epilepticus (SE). 8.The patients had a history of alcohol or drug abuse or dependence. 9.The patients had autoimmune diseases or significant immune interferences such as allergy infection and so on.

Design outcomes

Primary

MeasureTime frame
IL-2;IL-1ß;IL-6;IL-8;IFN-?;CRP;TNF-a;IL-4;IL-10;

Countries

China

Contacts

Public ContactRong Yin

Neurology Department of the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army

yin_rong_@163.com+86 13919930466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026